SPRINGWORKS THERAPEUTICS, INC. (SWTX) Social Stream
SpringWorks Therapeutics Inc (SWTX) Price Targets From Analysts
Use the tables below to see what analysts covering SpringWorks Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 4 | $137 | $92 | $111.5 | $56.9 | 95.96% |
| 2022-02-24 | 4 | $137 | $105 | $114.75 | $56.9 | 101.67% |
| 2022-02-25 | 4 | $137 | $101 | $113.25 | $56.9 | 99.03% |
| 2022-03-01 | 5 | $142 | $101 | $114.5 | $56.9 | 101.23% |
The Trend in the Analyst Price Target
SWTX's average price target has moved up $4.25 over the prior 44 weeks.
Over the past 46 weeks, SWTX's average upside potential has been 54.48%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-26 | 0 | 124 | 104 | 110.00 | 84.89 | 29.58% |
| 2021-08-05 | 0 | 136 | 104 | 117.00 | 86.01 | 36.03% |
| 2021-08-07 | 0 | 137 | 104 | 117.25 | 81.85 | 43.25% |
| 2021-08-14 | 0 | 137 | 104 | 117.25 | 75.31 | 55.69% |
| 2021-09-04 | 0 | 137 | 104 | 117.25 | 72.00 | 62.85% |
SWTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 120 days, SWTX's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SWTX as an investment opportunity.
- SpringWorks Therapeutics Inc's average analyst price target is higher than 348.4% of Pharmaceutical Products stocks.
- In terms of how SpringWorks Therapeutics Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 73.21% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, SpringWorks Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 318.89% of them.
- SpringWorks Therapeutics Inc's variance in analysts' estimates is lower than -9.21% of Pharmaceutical Products stocks.
Stocks similar to SpringWorks Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SRNE, SGMO, and SANA.
What is the outlook for SWTX? Use POWR Ratings for clearer insight into price direction.